These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14556042)

  • 1. Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists.
    Montastuc JL; Bongard V; Lapeyre-Mestre M
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):685-8. PubMed ID: 14556042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.
    Patino FG; Allison J; Olivieri J; Mudano A; Juarez L; Person S; Mikuls TR; Moreland L; Kovac SH; Saag KG
    Arthritis Rheum; 2003 Jun; 49(3):293-9. PubMed ID: 12794782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.
    Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ;
    Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxibs: evolution of prescription's behaviour in France.
    Biga J; Gony M; Bourrel R; Souche A; Sommet A; Pathak A; Sciortino V; Taboulet F; Grand A; Lapeyre-Mestre M; Montastruc JL
    Fundam Clin Pharmacol; 2007 Jun; 21(3):317-25. PubMed ID: 17521301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global safety of coxibs and NSAIDs.
    Pham K; Hirschberg R
    Curr Top Med Chem; 2005; 5(5):465-73. PubMed ID: 15974941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students.
    Durrieu G; Hurault C; Damase-Michel C; Montastruc JL
    Fundam Clin Pharmacol; 2010 Aug; 24(4):423-7. PubMed ID: 19845768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescription of cyclooxygenase-2 inhibitors: an intervention strategy in primary care].
    Rosich I; Soler M; Tomás R; Crusat D
    Gac Sanit; 2005; 19(3):229-34. PubMed ID: 15960956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.
    Bongard V; Ménard-Taché S; Bagheri H; Kabiri K; Lapeyre-Mestre M; Montastruc JL
    Br J Clin Pharmacol; 2002 Oct; 54(4):433-6. PubMed ID: 12392593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.
    Phueanpinit P; Pongwecharak J; Sumanont S; Krska J; Jarernsiripornkul N
    J Eval Clin Pract; 2017 Dec; 23(6):1387-1394. PubMed ID: 28809071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serious gastrointestinal effects of nonsteroidal anti-inflammatory drugs (NSAIDS) in a prospective study in Morocco].
    Benkirane R; El Kihal L; Nabil S; Benchekroun-Belabbés A; El Feydi AE; Soulaymani R
    Sante; 2005; 15(2):113-7. PubMed ID: 16061449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxibs and NSAIDs--clearing the air.
    Moskowitz RW; Abramson SB; Berenbaum F
    Osteoarthritis Cartilage; 2005 Jul; 13(7):545-7. PubMed ID: 15979006
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients' knowledge of adverse reactions to current medications.
    Cullen G; Kelly E; Murray FE
    Br J Clin Pharmacol; 2006 Aug; 62(2):232-6. PubMed ID: 16842399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs.
    Gunnarsdóttir AI; Kinnear M
    Pharm World Sci; 2005 Aug; 27(4):316-20. PubMed ID: 16228631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing NSAID-induced gastrointestinal complications.
    Drug Ther Bull; 2011 Feb; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
    García Rodríguez LA; Barreales Tolosa L
    Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
    Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
    J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of nonsteroidal anti-inflammatory drugs in physiatry: balancing risks and benefits in pain management.
    Kaplan RJ
    Am J Phys Med Rehabil; 2005 Nov; 84(11):885-94. PubMed ID: 16244527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].
    Doupe M; Katz A; Kvern B; Manness LJ; Metge C; Thomson GT; Morrison L; Rother K
    BMC Health Serv Res; 2004 Aug; 4(1):21. PubMed ID: 15327694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.